Pliant Therapeutics (PLRX) Non Operating Income (2019 - 2020)
Pliant Therapeutics (PLRX) reported Non Operating Income of -$97000.0 for Q4 2020, up 42.26% year-over-year from -$68184.1 in Q1 2020, and down 276.36% quarter-over-quarter from $55000.0 in Q3 2020.
Pliant Therapeutics (PLRX) Non Operating Income (2019 - 2020) Analysis & Trends
Pliant Therapeutics (PLRX) has 2 years of Non Operating Income data on file, last reported at -$97000.0 in Q4 2020.
- Non Operating Income for Q4 2020 came in at -$97000.0, up 42.26% year-over-year; the trailing twelve-month figure through Dec 2020 was -$346000.0 (changed N/A YoY), and the FY2020 annual result was -$366000.0, down 69.44% from the prior year.
- Non Operating Income fell to -$97000.0 in Q4 2020 per PLRX's latest filing, from $55000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $55000.0 in Q3 2020 and troughed at -$168000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 9.35 Mn |
| 10 | Pliant Therapeutics | 74.16 Mn | 74.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -97,000.00 |
| Sep 30, 2020 | 55,000.00 |
| Jun 30, 2020 | -136,000.00 |
| Dec 31, 2019 | -168,000.00 |
| Sep 30, 2019 | -41,000.00 |
| Jun 30, 2019 | -21,000.00 |